valproic acid has been researched along with Adolescent Myoclonic Epilepsy in 86 studies
Valproic Acid: A fatty acid with anticonvulsant and anti-manic properties that is used in the treatment of EPILEPSY and BIPOLAR DISORDER. The mechanisms of its therapeutic actions are not well understood. It may act by increasing GAMMA-AMINOBUTYRIC ACID levels in the brain or by altering the properties of VOLTAGE-GATED SODIUM CHANNELS.
valproic acid : A branched-chain saturated fatty acid that comprises of a propyl substituent on a pentanoic acid stem.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Drug-induced acute pancreatitis is a rare condition in childhood, and information about the incidence of valproic acid-induced acute pancreatitis in the pediatric population is scarce." | 7.79 | Valproic acid-induced pancreatitis in a 15-year-old boy with juvenile myoclonic epilepsy. ( Talvik, I; Talvik, T; Uibo, O; Veri, K, 2013) |
| "We describe four children with Dravet syndrome treated with the combination of valproic acid (VPA) and topiramate (TPM) who developed transient liver toxicity." | 7.74 | Acute hepatic injury in four children with Dravet syndrome: valproic acid, topiramate or acetaminophen? ( Ceulemans, B; Gunning, B; Leroy, PL; Nicolai, J; Vles, JS, 2008) |
| " For efficacy, a greater proportion of participants in the topiramate group had a 50% or greater reduction in primarily generalized tonic-clonic seizures (PGTCS), compared with participants in the placebo group (RR 4." | 5.12 | Topiramate for juvenile myoclonic epilepsy. ( Liu, J; Tai, YJ; Wang, LN, 2021) |
| " For efficacy, a greater proportion of participants in the topiramate group had a 50% or more reduction in primarily generalized tonic-clonic seizures (PGTCS) compared with participants in the placebo group." | 5.01 | Topiramate for juvenile myoclonic epilepsy. ( Liu, J; Wang, LN; Wang, YP, 2019) |
| " For efficacy, a greater proportion of participants in the topiramate group had a 50% or more reduction in primarily generalized tonic-clonic seizures (PGTCS) compared with participants in the placebo group." | 4.95 | Topiramate monotherapy for juvenile myoclonic epilepsy. ( Liu, J; Wang, LN; Wang, YP, 2017) |
| " For the efficacy, a greater proportion of participants in the topiramate group had a 50% or more reduction in primarily generalized tonic-clonic seizures (PGTCS) compared with participants in the placebo group." | 4.91 | Topiramate monotherapy for juvenile myoclonic epilepsy. ( Liu, J; Wang, LN; Wang, YP, 2015) |
| "Drug-induced acute pancreatitis is a rare condition in childhood, and information about the incidence of valproic acid-induced acute pancreatitis in the pediatric population is scarce." | 3.79 | Valproic acid-induced pancreatitis in a 15-year-old boy with juvenile myoclonic epilepsy. ( Talvik, I; Talvik, T; Uibo, O; Veri, K, 2013) |
| "We describe four children with Dravet syndrome treated with the combination of valproic acid (VPA) and topiramate (TPM) who developed transient liver toxicity." | 3.74 | Acute hepatic injury in four children with Dravet syndrome: valproic acid, topiramate or acetaminophen? ( Ceulemans, B; Gunning, B; Leroy, PL; Nicolai, J; Vles, JS, 2008) |
| "Since its initial 1957 description, juvenile myoclonic epilepsy (JME) has been recognized as a common epileptic syndrome worldwide." | 2.55 | Juvenile myoclonic epilepsy: Challenges on its 60th anniversary. ( Yacubian, EM, 2017) |
| "Myoclonic jerks are frequently the debut symptom, while tonic-clonic seizures appear later on." | 2.48 | [Juvenile myoclonic epilepsy]. ( Markhus, R; Nakken, KO; Selmer, KK; Syvertsen, MR, 2012) |
| "Juvenile myoclonic epilepsy is a common idiopathic generalized epileptic syndrome that includes generalized myoclonic seizures and commonly generalized tonic-clonic and generalized absence seizures." | 2.45 | The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent? ( Abou-Khalil, B; Montouris, G, 2009) |
| "Drug treatment of juvenile myoclonic epilepsy (JME) is mainly based on clinical experience and prospective and retrospective studies, with little evidence from randomized clinical trials." | 2.44 | Treatment of juvenile myoclonic epilepsy. ( Auvin, S, 2008) |
| "Most idiopathic generalized epilepsy (IGE) begins in childhood." | 2.43 | Management guidelines for children with idiopathic generalized epilepsy. ( Camfield, C; Camfield, P, 2005) |
| "Absence seizures were significantly associated with no-remission at multivariable multinomial logistic regression analysis." | 1.72 | Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients. ( Cerulli Irelli, E; Di Bonaventura, C; Fanella, M; Fattouch, J; Giallonardo, AT; Manfredi, M; Morano, A; Orlando, B; Salamone, EM, 2022) |
| "Patients with juvenile myoclonic epilepsy (JME) are especially prone to having antiseizure medications (ASMs) withdrawal seizures (WS)." | 1.72 | Antiseizure Medications Withdrawal Seizures in Patients with Juvenile Myoclonic Epilepsy. ( Ekstein, D; Eyal, S; Hofi, E; Khana Levy, N; Medvedovsky, M; Nassar, M, 2022) |
| "This study aimed to evaluate antiseizure medication (ASM) use in patients with JME." | 1.72 | Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020. ( Aydın, K; Cansu, A; Esenülkü, G; Haspolat, Ş; İnce, T; Kılıç, B; Okuyaz, Ç; Polat, BG; Serdaroğlu, A; Serdaroğlu, E; Tekgül, H; Topçu, Y, 2022) |
| "Under lamotrigine, seizure aggravation was observed in 15 patients (two patients during levetiracetam, one patient during zonisamide, none during phenobarbital and valproic acid)." | 1.62 | Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy. ( Beier, CP; Gesche, J; Hjalgrim, H; Rubboli, G, 2021) |
| "The most common syndrome was juvenile myoclonic epilepsy (JME), diagnosed in 44." | 1.56 | Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center. ( Barone, FA; Cerulli Irelli, E; Di Bonaventura, C; Fanella, M; Fattouch, J; Fisco, G; Giallonardo, AT; Manfredi, M; Morano, A; Orlando, B, 2020) |
| "Only 29 (33%) were seizure-free." | 1.51 | Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy. ( Baftiu, A; Enger, U; Fløgstad, I; Johannessen Landmark, C; Johannessen, SI; Koht, J; Syvertsen, M, 2019) |
| "Juvenile myoclonic epilepsy is often regarded as a benign epileptic syndrome, but in this setting, half of the individuals with JME have refractory epilepsy with only about a quarter of those seizure-free in the previous year." | 1.48 | Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center. ( Cação, G; Mannan, S; Parra, J; Sander, JW; Sisodiya, SM, 2018) |
| " All patients were under valproate (VPA) treatment, and the mean VPA dosage was 783." | 1.48 | Frontal lobe cognitive functions and electroencephalographic features in juvenile myoclonic epilepsy. ( Ak, PD; Ataklı, D; Keskinkılıç, C; Pulat, TA; Sezikli, S; Tekin, B, 2018) |
| "Children with Childhood Absence Epilepsy (CAE) may develop generalized tonic-clonic seizure or juvenile myoclonic epilepsy." | 1.48 | Childhood Absence Epilepsy evolving to Eyelid Myoclonia with Absence Epilepsy. ( Fazzi, E; Galli, J; Giordano, L; Malerba, L; Micheletti, S, 2018) |
| "Three study groups: - 1) juvenile myoclonic epilepsy (N=40) [drug naïve (N=20); On sodium valproate (SVA) (N=20)]; 2) symptomatic partial epilepsy (N=40) [drug naïve (N=20); On carbamazepine (CBZ) (N=20)]; 3) healthy controls (N=40) completed 3 standardized sleep questionnaires - Epworth Sleepiness Scale, Pittsburgh Sleep Quality Index, and NIMHANS Comprehensive Sleep Disorders Questionnaire." | 1.46 | Comparing sleep profiles between patients with juvenile myoclonic epilepsy and symptomatic partial epilepsy: Sleep questionnaire-based study. ( Nagappa, M; Nayak, C; Saraswati, N; Sinha, S; Taly, AB; Thennarasu, K, 2017) |
| "Generalized tonic-clonic seizures (GTCS) were found in 150/156 patients." | 1.43 | Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China. ( Bai, J; Chen, BB; Dang, JX; Deng, YC; Jia, FY; Jia, SS; Jiang, Z; Jin, L; Liu, YH; Wang, B; Wang, CT; Wang, D; Wang, JX; Wang, L; Wang, TC; Zhang, L; Zhang, WJ; Zhao, G, 2016) |
| "Coexisting psychiatric disorders (PDs) were found in 33." | 1.40 | Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy. ( Bana, AK; Jayalakshmi, S; Mohandas, S; Sailaja, S; Somayajula, S; Vooturi, S, 2014) |
| "Fifty-four patients were included, with juvenile myoclonic epilepsy (JME) in 23 (42." | 1.40 | Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies. ( Aiguabella, M; Falip, M; Juvany, R; Leiva, E; Miró, J; Salas-Puig, J; Santurino, M; Veciana, M, 2014) |
| "A 27-year-old woman was diagnosed with juvenile myoclonic epilepsy since the age of 13 and was on valproate therapy." | 1.40 | Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate? ( Acharya, M; Kumawat, BL; Parekh, J; Sharma, C, 2014) |
| "She also has cerebellar ataxia in her extremities." | 1.35 | [Case of juvenile myoclonic epilepsy misdiagnosed as simple partial seizure for more than 60 years]. ( Komori, T; Mizoi, Y; Shimazu, K; Sumita, N; Tamura, N; Yamamoto, T, 2009) |
| "Juvenile myoclonic epilepsy developed in two patients, and cryptogenic partial epilepsy in another." | 1.33 | Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients. ( Auvin, S; Badinand, N; De Bellecize, J; Isnard, H; Lamblin, MD; Motte, J; Pandit, F; Vallée, L; Villeneuve, N, 2006) |
| "Mean dosage of valproic acid was 800 mg/d in both groups (13 mg/kg and 12." | 1.33 | Comparison of valporic acid efficacy in familial versus sporadic cases of juvenile myoclonic epilepsy. ( Mohammad Ali, S; Motamedi, M; Rahmat, M, 2006) |
| "Lamotrigine is an anti-epileptic drug considered as a first-line therapy in idiopathic generalised epilepsy." | 1.33 | [Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine]. ( Guillon, B; Maiga, Y; Nogues, B, 2006) |
| "We studied 14 patients with juvenile myoclonic epilepsy (JME), 19 patients with refractory localization-related epilepsy (RLE) and 20 healthy volunteers who were matched for age and sex." | 1.32 | Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients. ( Keränen, T; Peltola, J; Rainesalo, S; Saransaari, P, 2003) |
| "Most cases of toxic epidermal necrolysis are drug induced." | 1.32 | Suspected lamotrigine-induced toxic epidermal necrolysis. ( Demiralay, E; Kilinç, M; Söğüt, A; Söğüt, AG; Uzar, H; Yilmaz, A, 2003) |
| "The recommended treatment for juvenile myoclonic epilepsy (JME) is valproate (VPA)." | 1.32 | Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy. ( Hardison, H; Khurana, DS; Kothare, SV; Legido, A; Melvin, JJ; Valencia, I, 2004) |
| "The clinical data on cases of Juvenile Myoclonic Epilepsy (JME) were analysed." | 1.31 | Juvenile myoclonic epilepsy--an experience from north western India. ( Panagariya, A; Sardana, V; Sureka, RK, 2001) |
| " Four of them suffered persistent seizures despite optimal VPA dosage and needed the addition of a second drug (lamotrigine in three cases, clobazam in one case)." | 1.31 | Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate. ( Calleja, S; Lahoz, CH; Ribacoba, R; Salas-Puig, J, 2001) |
| "A young woman with juvenile myoclonic epilepsy had recurrent attacks of myoclonic status epilepticus related to a long history of limited compliance and irregular sleep." | 1.31 | Myoclonic status epilepticus: video presentation. ( Andermann, E; Andermann, F; Badhwar, A; Siren, A, 2002) |
| "Fourteen patients with juvenile myoclonic epilepsy (JME) were treated with a single low dose of a sustained-release preparation of sodium valproate (VPA, 500 mg daily)." | 1.31 | Low dose sodium valproate in the treatment of juvenile myoclonic epilepsy. ( Alexiou, D; Angelopoulos, P; Armentsoudis, P; Baloyannis, S; Delithanasis, I; Dimitrakoudi, E; Hamlatzis, P; Karlovassitou-Koniari, A, 2002) |
| "The PGE had characteristics of both childhood absence epilepsy (CAE) and juvenile myoclonic epilepsy (JME)." | 1.30 | Primary ciliary dyskinesia syndrome and primary generalised epilepsy. ( Shepherd, RC, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (1.16) | 18.2507 |
| 2000's | 34 (39.53) | 29.6817 |
| 2010's | 40 (46.51) | 24.3611 |
| 2020's | 11 (12.79) | 2.80 |
| Authors | Studies |
|---|---|
| Baheti, N | 1 |
| Rathore, C | 1 |
| Bansal, AR | 1 |
| Shah, S | 1 |
| Veedu, HK | 1 |
| Prakash, S | 1 |
| Kanhere, K | 1 |
| Jaiswal, SK | 1 |
| Jukkarwala, A | 1 |
| Murthy, JMK | 1 |
| Radhakrishnan, K | 1 |
| Cerulli Irelli, E | 2 |
| Morano, A | 2 |
| Orlando, B | 2 |
| Salamone, EM | 1 |
| Fanella, M | 2 |
| Fattouch, J | 2 |
| Manfredi, M | 2 |
| Giallonardo, AT | 2 |
| Di Bonaventura, C | 2 |
| Liu, J | 4 |
| Tai, YJ | 1 |
| Wang, LN | 4 |
| Moon, JU | 1 |
| Lee, JY | 1 |
| Kim, KY | 1 |
| Eom, TH | 1 |
| Kim, YH | 1 |
| Lee, IG | 1 |
| Hofi, E | 1 |
| Medvedovsky, M | 1 |
| Nassar, M | 1 |
| Khana Levy, N | 1 |
| Eyal, S | 1 |
| Ekstein, D | 1 |
| Kılıç, B | 1 |
| Serdaroğlu, E | 1 |
| Polat, BG | 1 |
| İnce, T | 1 |
| Esenülkü, G | 1 |
| Topçu, Y | 1 |
| Serdaroğlu, A | 1 |
| Haspolat, Ş | 1 |
| Tekgül, H | 1 |
| Okuyaz, Ç | 1 |
| Cansu, A | 1 |
| Aydın, K | 1 |
| Tabrizi, N | 1 |
| Zarvani, A | 1 |
| Rezaei, P | 1 |
| Cheraghmakani, H | 1 |
| Alizadeh-Navaei, R | 1 |
| Liguori, S | 1 |
| Barone, FA | 1 |
| Fisco, G | 1 |
| Gesche, J | 1 |
| Hjalgrim, H | 1 |
| Rubboli, G | 1 |
| Beier, CP | 1 |
| Milano, C | 1 |
| Turco, F | 1 |
| Pizzanelli, C | 1 |
| Bonanni, E | 1 |
| Siciliano, G | 1 |
| Fornai, F | 1 |
| Giorgi, FS | 1 |
| Ascoli, M | 1 |
| Mastroianni, G | 1 |
| Gasparini, S | 1 |
| Striano, P | 1 |
| Cianci, V | 1 |
| Neri, S | 1 |
| Bova, V | 1 |
| Mammì, A | 1 |
| Gambardella, A | 1 |
| Labate, A | 1 |
| Aguglia, U | 1 |
| Ferlazzo, E | 1 |
| Wang, YP | 3 |
| Mekky, JF | 1 |
| Elbhrawy, SM | 1 |
| Boraey, MF | 1 |
| Omar, HM | 1 |
| Xu, L | 1 |
| Guo, D | 1 |
| Liu, YY | 1 |
| Qiao, DD | 1 |
| Ye, JY | 1 |
| Xue, R | 1 |
| Cação, G | 1 |
| Parra, J | 1 |
| Mannan, S | 1 |
| Sisodiya, SM | 1 |
| Sander, JW | 1 |
| Sezikli, S | 1 |
| Pulat, TA | 1 |
| Tekin, B | 1 |
| Ak, PD | 1 |
| Keskinkılıç, C | 1 |
| Ataklı, D | 1 |
| Galli, J | 1 |
| Micheletti, S | 1 |
| Malerba, L | 1 |
| Fazzi, E | 1 |
| Giordano, L | 2 |
| Huang, Q | 1 |
| Yu, L | 1 |
| Ma, M | 1 |
| Qi, H | 1 |
| Wu, Y | 1 |
| Johannessen Landmark, C | 2 |
| Fløgstad, I | 2 |
| Baftiu, A | 2 |
| Syvertsen, M | 2 |
| Enger, U | 2 |
| Koht, J | 2 |
| Johannessen, SI | 2 |
| Gürer, R | 1 |
| Aydın, Ş | 1 |
| Özkara, Ç | 1 |
| Park, KM | 1 |
| Kim, SH | 1 |
| Nho, SK | 1 |
| Shin, KJ | 1 |
| Park, J | 1 |
| Ha, SY | 1 |
| Kim, SE | 1 |
| Papadavid, E | 1 |
| Evangelia, P | 1 |
| Panayiotides, I | 1 |
| Ioannis, P | 1 |
| Makris, M | 1 |
| Michael, M | 1 |
| Giatrakou, S | 1 |
| Sophia, G | 1 |
| Dalamaga, M | 1 |
| Maria, D | 1 |
| Stavrianeas, N | 2 |
| Rigopoulos, D | 1 |
| Dimitrios, R | 1 |
| Machado, RA | 1 |
| García, VF | 1 |
| Astencio, AG | 1 |
| Cuartas, VB | 1 |
| Shetty, A | 1 |
| Khardenavis, S | 1 |
| Deshpande, A | 1 |
| Miró, J | 1 |
| Aiguabella, M | 1 |
| Veciana, M | 1 |
| Juvany, R | 1 |
| Santurino, M | 1 |
| Leiva, E | 1 |
| Salas-Puig, J | 2 |
| Falip, M | 1 |
| Krishnan, P | 2 |
| Sinha, S | 4 |
| Taly, AB | 4 |
| Ramachandraiah, CT | 2 |
| Rao, S | 2 |
| Satishchandra, P | 2 |
| Jayalakshmi, S | 1 |
| Vooturi, S | 1 |
| Bana, AK | 1 |
| Sailaja, S | 1 |
| Somayajula, S | 1 |
| Mohandas, S | 1 |
| Veri, K | 1 |
| Uibo, O | 1 |
| Talvik, I | 1 |
| Talvik, T | 1 |
| Sharma, C | 1 |
| Parekh, J | 1 |
| Kumawat, BL | 1 |
| Acharya, M | 1 |
| Asadi-Pooya, AA | 1 |
| Hashemzehi, Z | 1 |
| Emami, M | 1 |
| Gélisse, P | 1 |
| Crespel, A | 1 |
| Kandemir, M | 1 |
| Gündüz, A | 1 |
| Uzun, N | 1 |
| Yeni, N | 1 |
| Kızıltan, M | 1 |
| Chowdhury, A | 1 |
| Brodie, MJ | 2 |
| Nayak, CS | 1 |
| Nagappa, M | 2 |
| Kandavel, T | 1 |
| Hernández-Vanegas, LE | 1 |
| Jara-Prado, A | 1 |
| Ochoa, A | 1 |
| Rodríguez Y Rodríguez, N | 1 |
| Durón, RM | 1 |
| Crail-Meléndez, D | 1 |
| Alonso, ME | 1 |
| Delgado-Escueta, AV | 1 |
| Martínez-Juárez, IE | 1 |
| Wang, L | 1 |
| Jiang, Z | 1 |
| Chen, BB | 1 |
| Wang, CT | 1 |
| Wang, JX | 1 |
| Bai, J | 1 |
| Wang, B | 1 |
| Jin, L | 1 |
| Zhang, WJ | 1 |
| Deng, YC | 1 |
| Zhao, G | 1 |
| Dang, JX | 1 |
| Wang, D | 1 |
| Jia, SS | 1 |
| Wang, TC | 1 |
| Jia, FY | 1 |
| Zhang, L | 1 |
| Liu, YH | 1 |
| Yacubian, EM | 2 |
| Saraswati, N | 1 |
| Nayak, C | 1 |
| Thennarasu, K | 1 |
| Auvin, S | 2 |
| Mizoi, Y | 1 |
| Sumita, N | 1 |
| Yamamoto, T | 1 |
| Komori, T | 1 |
| Tamura, N | 1 |
| Shimazu, K | 1 |
| Montouris, G | 1 |
| Abou-Khalil, B | 1 |
| Somerville, ER | 1 |
| Cook, MJ | 1 |
| O'Brien, TJ | 1 |
| Piccinelli, P | 1 |
| Beghi, E | 1 |
| Borgatti, R | 1 |
| Ferri, M | 1 |
| Romeo, A | 1 |
| Termine, C | 1 |
| Viri, M | 1 |
| Zucca, C | 1 |
| Balottin, U | 1 |
| Choi, KH | 1 |
| Nam, TS | 1 |
| Kim, JT | 1 |
| Choi, SM | 1 |
| Park, MS | 1 |
| Kim, BC | 1 |
| Kim, MK | 1 |
| Cho, KH | 1 |
| Katshu, MZ | 1 |
| Bhattacharya, A | 1 |
| Nizamie, SH | 1 |
| Morrison, N | 1 |
| Thomas, R | 1 |
| Smith, P | 1 |
| Angus-Leppan, H | 1 |
| Syvertsen, MR | 1 |
| Markhus, R | 1 |
| Selmer, KK | 1 |
| Nakken, KO | 1 |
| Karlov, VA | 1 |
| Freĭdkova, NV | 1 |
| Rusanova, LV | 1 |
| Erdem, H | 1 |
| Yiğit, A | 1 |
| Culcuoğlu, A | 1 |
| Mutluer, N | 1 |
| Mehndiratta, MM | 1 |
| Aggarwal, P | 1 |
| Aiba, H | 1 |
| Rainesalo, S | 1 |
| Saransaari, P | 1 |
| Peltola, J | 1 |
| Keränen, T | 1 |
| King, M | 1 |
| Söğüt, A | 1 |
| Yilmaz, A | 1 |
| Kilinç, M | 1 |
| Söğüt, AG | 1 |
| Demiralay, E | 1 |
| Uzar, H | 1 |
| Chifari, R | 1 |
| Piazzini, A | 1 |
| Turner, K | 1 |
| Canger, R | 1 |
| Canevini, MP | 1 |
| Wolf, P | 1 |
| Morris, GL | 1 |
| Hammer, AE | 1 |
| Kustra, RP | 1 |
| Messenheimer, JA | 1 |
| Kothare, SV | 1 |
| Valencia, I | 1 |
| Khurana, DS | 1 |
| Hardison, H | 1 |
| Melvin, JJ | 1 |
| Legido, A | 1 |
| Camfield, C | 1 |
| Camfield, P | 1 |
| Trost, LF | 1 |
| Wender, RC | 1 |
| Suter, CC | 1 |
| Rosenberg, JH | 1 |
| Brixner, DI | 1 |
| Von Worley, AM | 1 |
| Gunter, MJ | 1 |
| Pandit, F | 1 |
| De Bellecize, J | 1 |
| Badinand, N | 1 |
| Isnard, H | 1 |
| Motte, J | 1 |
| Villeneuve, N | 1 |
| Lamblin, MD | 1 |
| Vallée, L | 1 |
| de Araujo Filho, GM | 1 |
| Pascalicchio, TF | 1 |
| Lin, K | 1 |
| Sousa, PS | 1 |
| Fregni, F | 1 |
| Boggio, PS | 1 |
| Valle, AC | 1 |
| Otachi, P | 1 |
| Thut, G | 1 |
| Rigonatti, SP | 1 |
| Marcolin, MA | 1 |
| Fecteau, S | 1 |
| Pascual-Leone, A | 1 |
| Fiore, L | 1 |
| Valente, K | 1 |
| Motamedi, M | 1 |
| Mohammad Ali, S | 1 |
| Rahmat, M | 1 |
| Welty, TE | 1 |
| Maiga, Y | 1 |
| Nogues, B | 1 |
| Guillon, B | 1 |
| Chakravarty, A | 1 |
| Mukherjee, A | 1 |
| Roy, D | 1 |
| Plattner, B | 1 |
| Pahs, G | 1 |
| Kindler, J | 1 |
| Williams, RP | 1 |
| Hall, RE | 1 |
| Mayer, H | 1 |
| Steiner, H | 1 |
| Feucht, M | 1 |
| Levisohn, PM | 1 |
| Holland, KD | 1 |
| Nicolai, J | 1 |
| Gunning, B | 1 |
| Leroy, PL | 1 |
| Ceulemans, B | 1 |
| Vles, JS | 1 |
| Tóth, V | 1 |
| Rásonyi, G | 1 |
| Fogarasi, A | 1 |
| Kovács, N | 1 |
| Auer, T | 1 |
| Janszky, J | 1 |
| Grewal, HK | 1 |
| Almullahassani, A | 1 |
| Grewal, J | 1 |
| Slater, JD | 1 |
| Alfradique, I | 1 |
| Vasconcelos, MM | 1 |
| Shepherd, RC | 1 |
| Fernando-Dongas, MC | 1 |
| Radtke, RA | 1 |
| VanLandingham, KE | 1 |
| Husain, AM | 1 |
| Biraben, A | 1 |
| Allain, H | 1 |
| Scarabin, JM | 1 |
| Schück, S | 1 |
| Edan, G | 1 |
| Panagariya, A | 1 |
| Sureka, RK | 1 |
| Sardana, V | 1 |
| Calleja, S | 1 |
| Ribacoba, R | 1 |
| Lahoz, CH | 1 |
| Badhwar, A | 1 |
| Siren, A | 1 |
| Andermann, E | 1 |
| Andermann, F | 1 |
| Karlovassitou-Koniari, A | 1 |
| Alexiou, D | 1 |
| Angelopoulos, P | 1 |
| Armentsoudis, P | 1 |
| Dimitrakoudi, E | 1 |
| Delithanasis, I | 1 |
| Hamlatzis, P | 1 |
| Baloyannis, S | 1 |
16 reviews available for valproic acid and Adolescent Myoclonic Epilepsy
| Article | Year |
|---|---|
Topiramate for juvenile myoclonic epilepsy.
Topics: Anticonvulsants; Humans; Myoclonic Epilepsy, Juvenile; Randomized Controlled Trials as Topic; Seizur | 2021 |
Diagnostic and therapeutic approach to drug-resistant juvenile myoclonic epilepsy.
Topics: Anticonvulsants; Female; Humans; Levetiracetam; Myoclonic Epilepsy, Juvenile; Pharmaceutical Prepara | 2021 |
Topiramate monotherapy for juvenile myoclonic epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Fructose; Humans; Myoclonic Epilepsy, Juvenile; Randomized Contr | 2017 |
Juvenile myoclonic epilepsy and sleep.
Topics: Adolescent; Adult; Circadian Rhythm; Electroencephalography; Epilepsy, Reflex; Female; Humans; Male; | 2018 |
Topiramate for juvenile myoclonic epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Humans; Myoclonic Epilepsy, Juvenile; Randomized Controlled Tria | 2019 |
Topiramate monotherapy for juvenile myoclonic epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Fructose; Humans; Myoclonic Epilepsy, Juvenile; Randomized Contr | 2015 |
Modern management of juvenile myoclonic epilepsy.
Topics: Electroencephalography; Female; Frontal Lobe; Humans; Male; Myoclonic Epilepsy, Juvenile; Phenotype; | 2016 |
Juvenile myoclonic epilepsy: Challenges on its 60th anniversary.
Topics: Age of Onset; Aging; Anniversaries and Special Events; Anticonvulsants; Humans; Myoclonic Epilepsy, | 2017 |
Treatment of juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Child, Preschool; Female; Humans; Infant; Lamotrigine; Le | 2008 |
The first line of therapy in a girl with juvenile myoclonic epilepsy: should it be valproate or a new agent?
Topics: Anticonvulsants; Congenital Abnormalities; Delayed-Action Preparations; Drug Design; Epilepsy, Gener | 2009 |
Efficacy of paroxetine in primary palmoplantar hyperhidrosis occurring with juvenile myoclonic epilepsy.
Topics: Adolescent; Anticonvulsants; Drug Therapy, Combination; Female; Hand; Humans; Hyperhidrosis; Myoclon | 2011 |
[Juvenile myoclonic epilepsy].
Topics: Adolescent; Anticonvulsants; Diagnosis, Differential; Electroencephalography; Female; Humans; Lamotr | 2012 |
[Juvenile myoclonic epilepsy].
Topics: Adolescent; Child; Diagnosis, Differential; Humans; Myoclonic Epilepsy, Juvenile; Prognosis; Valproi | 2002 |
Management guidelines for children with idiopathic generalized epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Electroencephalography; Epilepsy, Absence; Epilepsy, Generalized | 2005 |
Juvenile myoclonic epilepsy: epidemiology, pathophysiology, and management.
Topics: Adolescent; Anticonvulsants; Child; Humans; Myoclonic Epilepsy, Juvenile; Valproic Acid | 2006 |
Juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Diagnosis, Differential; Electroencephalography; Humans; | 2007 |
7 trials available for valproic acid and Adolescent Myoclonic Epilepsy
| Article | Year |
|---|---|
Levetiracetam in genetic generalized epilepsy: A prospective unblinded active-controlled trial.
Topics: Adolescent; Adult; Anticonvulsants; Epilepsy, Generalized; Female; Humans; Levetiracetam; Male; Myoc | 2019 |
A randomized open-label observational study to compare the efficacy and tolerability between topiramate and valproate in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Electroencephalography; Female; Fructose; Humans; Male; Myoclonic Epilepsy, Juven | 2013 |
Efficacy and tolerability of lamotrigine in juvenile myoclonic epilepsy in adults: a prospective, unblinded randomized controlled trial.
Topics: Adolescent; Adult; Anticonvulsants; Female; Humans; Lamotrigine; Male; Middle Aged; Myoclonic Epilep | 2013 |
Effect of sodium valproate on somatosensory evoked potentials in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Case-Control Studies; Evoked Potentials, Somatosensory; Female; | 2001 |
Lamotrigine for patients with juvenile myoclonic epilepsy following prior treatment with valproate: results of an open-label study.
Topics: Adolescent; Anticonvulsants; Child; Drug Evaluation; Humans; Lamotrigine; Myoclonic Epilepsy, Juveni | 2004 |
Homeostatic effects of plasma valproate levels on corticospinal excitability changes induced by 1Hz rTMS in patients with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Combined Modality Therapy; Homeostasis; Humans; Myoclonic Epilep | 2006 |
Topiramate or valproate in patients with juvenile myoclonic epilepsy: a randomized open-label comparison.
Topics: Adolescent; Adult; Aged; Anticonvulsants; Child; Double-Blind Method; Female; Fructose; Humans; Magn | 2007 |
63 other studies available for valproic acid and Adolescent Myoclonic Epilepsy
| Article | Year |
|---|---|
Treatment outcomes in drug resistant juvenile myoclonic epilepsy: Valproate resistance may not be the end of the road.
Topics: Anticonvulsants; Female; Humans; Male; Myoclonic Epilepsy, Juvenile; Pharmaceutical Preparations; Tr | 2021 |
Seizure outcome trajectories in a well-defined cohort of newly diagnosed juvenile myoclonic epilepsy patients.
Topics: Anticonvulsants; Female; Humans; Myoclonic Epilepsy, Juvenile; Retrospective Studies; Seizures; Valp | 2022 |
Comparative analysis of background EEG activity in juvenile myoclonic epilepsy during valproic acid treatment: a standardized, low-resolution, brain electromagnetic tomography (sLORETA) study.
Topics: Brain; Child; Electroencephalography; Electromagnetic Phenomena; Frontal Lobe; Humans; Myoclonic Epi | 2022 |
Antiseizure Medications Withdrawal Seizures in Patients with Juvenile Myoclonic Epilepsy.
Topics: Anticonvulsants; Female; Humans; Myoclonic Epilepsy, Juvenile; Seizures; Substance Withdrawal Syndro | 2022 |
Trends in the choice of antiseizure medications in juvenile myoclonic epilepsy: A retrospective multi-center study from Turkey between 2010 and 2020.
Topics: Adolescent; Anticonvulsants; Child; Female; Humans; Lamotrigine; Levetiracetam; Male; Myoclonic Epil | 2022 |
Is topiramate effective and tolerated in young people with juvenile myoclonic epilepsy? A Cochrane Review summary with commentary.
Topics: Adolescent; Anticonvulsants; Humans; Myoclonic Epilepsy, Juvenile; Topiramate; Valproic Acid | 2020 |
Persistent treatment resistance in genetic generalized epilepsy: A long-term outcome study in a tertiary epilepsy center.
Topics: Adult; Anticonvulsants; Cohort Studies; Drug Resistant Epilepsy; Electroencephalography; Epilepsy, G | 2020 |
Risk factors of paradoxical reactions to anti-seizure medication in genetic generalized epilepsy.
Topics: Adult; Anticonvulsants; Epilepsy, Generalized; Humans; Lamotrigine; Levetiracetam; Myoclonic Epileps | 2021 |
Response to levetiracetam or lamotrigine in subjects with Juvenile Myoclonic Epilepsy previously treated with valproic acid: A single center retrospective study.
Topics: Anticonvulsants; Female; Humans; Lamotrigine; Levetiracetam; Myoclonic Epilepsy, Juvenile; Retrospec | 2021 |
Sleep architecture in patients with Juvenile Myoclonic Epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Electroencephalography; Female; Humans; Male; Myoclonic Epilepsy | 2017 |
Juvenile myoclonic epilepsy refractory to treatment in a tertiary referral center.
Topics: Adolescent; Adult; Anticonvulsants; Child; Drug Resistant Epilepsy; Electroencephalography; Female; | 2018 |
Frontal lobe cognitive functions and electroencephalographic features in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Attention; Cognition; Electroencephalography; Exec | 2018 |
Childhood Absence Epilepsy evolving to Eyelid Myoclonia with Absence Epilepsy.
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Disease Progression; Electroencephalography; E | 2018 |
Novel SCN2A mutation in a family associated with juvenile-onset myoclonus: Case report.
Topics: Adult; Anticonvulsants; Ataxia; Carbamazepine; Disease Progression; Drug Resistant Epilepsy; Electro | 2019 |
Long-term follow-up with therapeutic drug monitoring of antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Drug Monitoring; Female; Follow-Up Studies; Humans; Lamotrigine; | 2019 |
Outcomes of low-dose valproic acid treatment in patients with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Cross-Sectional Studies; Dose-Response Relationship, Drug; Femal | 2019 |
Treatment and challenges with antiepileptic drugs in patients with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Cohort Studies; Female; Humans; Lamotrigine; Levetiracetam; Male | 2019 |
Pityriasis rosea-like eruption associated with lamotrigine.
Topics: Adult; Anticonvulsants; Drug Eruptions; Drug Hypersensitivity; Female; Humans; Lamotrigine; Myocloni | 2013 |
Ophthalmoplegic migraine with isolated third cranial nerve palsy in a known case of juvenile myoclonic epilepsy.
Topics: Adult; Analgesics; Anticonvulsants; Female; Humans; Myoclonic Epilepsy, Juvenile; Ophthalmoplegic Mi | 2013 |
Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.
Topics: Adult; Anticonvulsants; Epilepsy, Absence; Epilepsy, Generalized; Female; Follow-Up Studies; Humans; | 2014 |
Altered polysomnographic profile in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Brain Waves; Case-Control Studies; Cross-Sectional Studies; Elec | 2014 |
Factors associated with lack of response to valproic acid monotherapy in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Electroencephalography; Female; Humans; Longitudinal Studies; Ma | 2014 |
Valproic acid-induced pancreatitis in a 15-year-old boy with juvenile myoclonic epilepsy.
Topics: Acute Disease; Adolescent; Anticonvulsants; Estonia; Humans; Male; Myoclonic Epilepsy, Juvenile; Pan | 2013 |
Juvenile myoclonic epilepsy with multiple sclerosis: is there a dual role for valproate?
Topics: Adult; Anticonvulsants; Brain; Diagnosis, Differential; Female; Humans; Magnetic Resonance Imaging; | 2014 |
Predictors of seizure control in patients with juvenile myoclonic epilepsy (JME).
Topics: Adolescent; Adult; Anticonvulsants; Case-Control Studies; Child; Electroencephalography; Female; Fol | 2014 |
Mixed myoclonic-absence status epilepticus in juvenile myoclonic epilepsy.
Topics: Anticonvulsants; Bipolar Disorder; Catatonia; Clonazepam; Electroencephalography; Epilepsies, Myoclo | 2015 |
Auditory startle response is normal in juvenile myoclonic epilepsy.
Topics: Acoustic Stimulation; Adolescent; Adult; Anticonvulsants; Case-Control Studies; Chi-Square Distribut | 2015 |
Pharmacological outcomes in juvenile myoclonic epilepsy: Support for sodium valproate.
Topics: Adolescent; Adult; Anticonvulsants; Child; Comorbidity; Drug Resistant Epilepsy; Female; Follow-Up S | 2016 |
Effect of valproate on the sleep microstructure of juvenile myoclonic epilepsy patients - a cross-sectional CAP based study.
Topics: Adolescent; Adult; Anticonvulsants; Arousal; Case-Control Studies; Cross-Sectional Studies; Female; | 2016 |
High-dose versus low-dose valproate for the treatment of juvenile myoclonic epilepsy: Going from low to high.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Child; Dose-Response Relationship, Drug; Electroen | 2016 |
Electroclinical aspects and therapy of Han patients with juvenile myoclonic epilepsy in northern China.
Topics: Adolescent; Adult; Anticonvulsants; Brain; Child; Child, Preschool; China; Electroencephalography; F | 2016 |
Comparing sleep profiles between patients with juvenile myoclonic epilepsy and symptomatic partial epilepsy: Sleep questionnaire-based study.
Topics: Adolescent; Adult; Anticonvulsants; Carbamazepine; Epilepsies, Partial; Female; Humans; Male; Myoclo | 2017 |
[Case of juvenile myoclonic epilepsy misdiagnosed as simple partial seizure for more than 60 years].
Topics: Aged; Cerebellar Ataxia; Diagnostic Errors; Electroencephalography; Electromyography; Epilepsies, Pa | 2009 |
Pregnancy treatment guidelines: throwing the baby out with the bath water.
Topics: Abnormalities, Drug-Induced; Anticonvulsants; Carbamazepine; Dose-Response Relationship, Drug; Femal | 2009 |
Neuropsychological and behavioural aspects in children and adolescents with idiopathic epilepsy at diagnosis and after 12 months of treatment.
Topics: Adolescent; Anticonvulsants; Attention; Carbamazepine; Chi-Square Distribution; Child; Child, Presch | 2010 |
Valproate associated diffuse alveolar hemorrhage.
Topics: Adolescent; Anticonvulsants; Hemorrhage; Humans; Lung Diseases; Male; Myoclonic Epilepsy, Juvenile; | 2011 |
Juvenile myoclonic epilepsy.
Topics: Adaptation, Psychological; Adult; Anticonvulsants; Female; Health Knowledge, Attitudes, Practice; Hu | 2012 |
Sleep disturbances in juvenile myoclonic epilepsy: a sleep questionnaire-based study.
Topics: Adolescent; Adult; Anticonvulsants; Cross-Sectional Studies; Electroencephalography; Female; Humans; | 2012 |
We must warn women about the risks of untreated, or ineffectively treated, epilepsy.
Topics: Anticonvulsants; Female; Health Knowledge, Attitudes, Practice; Humans; Myoclonic Epilepsy, Juvenile | 2012 |
[Complex therapy of idiopathic forms of epilepsy with small doses of valproates and levetiracetam].
Topics: Adolescent; Anticonvulsants; Child; Child, Preschool; Drug Therapy, Combination; Epilepsy, Absence; | 2012 |
Clinical expression and EEG features of patients with juvenile myoclonic epilepsy (JME) from North India.
Topics: Adult; Anticonvulsants; Electroencephalography; Female; Humans; Male; Myoclonic Epilepsy, Juvenile; | 2002 |
Uptake of GABA and activity of GABA-transaminase in platelets from epileptic patients.
Topics: 4-Aminobutyrate Transaminase; Adult; Anticonvulsants; Blood Platelets; Case-Control Studies; Dose-Re | 2003 |
The new patient with a first seizure.
Topics: Adult; Anticonvulsants; Causality; Diagnosis, Differential; Electroencephalography; Genetic Counseli | 2003 |
Suspected lamotrigine-induced toxic epidermal necrolysis.
Topics: Adult; Anticonvulsants; Drug Therapy, Combination; Female; Humans; Lamotrigine; Myoclonic Epilepsy, | 2003 |
Reflex writing seizures in two siblings with juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Attention; Electroencephalography; Epilepsy, Reflex; Evoked Pote | 2004 |
Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Dose-Response Relationship, Drug; Drug Interactions; Drug | 2004 |
Management of epilepsy in adults. Diagnosis guidelines.
Topics: Adolescent; Adult; Algorithms; Anticonvulsants; Child; Diagnosis, Differential; Electroencephalograp | 2005 |
Benign myoclonic epilepsy in infants: electroclinical features and long-term follow-up of 34 patients.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Cerebral Cortex; Child; Child, Preschool; Comorbid | 2006 |
Neuropsychiatric profiles of patients with juvenile myoclonic epilepsy treated with valproate or topiramate.
Topics: Adolescent; Anticonvulsants; Anxiety Disorders; Cross-Sectional Studies; Depressive Disorder; Female | 2006 |
Comparison of valporic acid efficacy in familial versus sporadic cases of juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Anticonvulsants; Child; Electroencephalography; Female; Humans; Magnetic Resonanc | 2006 |
[Exacerbation of tonicoclonic seizures in a juvenile myoclonic epileptic taking lamotrigine].
Topics: Adult; Anticonvulsants; Electroencephalography; Epilepsy, Tonic-Clonic; Humans; Lamotrigine; Male; M | 2006 |
Observations on juvenile myoclonic epilepsy amongst ethnic Bengalees in West Bengal--an Eastern Indian State.
Topics: Abnormalities, Drug-Induced; Age of Onset; Anticonvulsants; Benzodiazepines; Clobazam; Electroenceph | 2007 |
Juvenile myoclonic epilepsy: a benign disorder? Personality traits and psychiatric symptoms.
Topics: Adolescent; Adult; Anticonvulsants; Child; Ethosuximide; Female; Fructose; Humans; Lamotrigine; Leve | 2007 |
Acute hepatic injury in four children with Dravet syndrome: valproic acid, topiramate or acetaminophen?
Topics: Acetaminophen; Analgesics, Non-Narcotic; Anticonvulsants; Chemical and Drug Induced Liver Injury; De | 2008 |
Juvenile myoclonic epilepsy starting in the eighth decade.
Topics: Aged; Anticonvulsants; Electroencephalography; Epilepsy, Tonic-Clonic; Female; Humans; Magnetic Reso | 2007 |
Partial agenesis of the corpus callosum in a patient with juvenile myoclonic epilepsy.
Topics: Adolescent; Agenesis of Corpus Callosum; Anticonvulsants; Chromosomes, Human, Pair 15; Corpus Callos | 2007 |
Primary ciliary dyskinesia syndrome and primary generalised epilepsy.
Topics: Adult; Anticonvulsants; Child; Child, Preschool; Ciliary Motility Disorders; Electroencephalography; | 1999 |
Characteristics of valproic acid resistant juvenile myoclonic epilepsy.
Topics: Adolescent; Anticonvulsants; Drug Resistance; Electroencephalography; Female; Humans; Magnetic Reson | 2000 |
Exacerbation of juvenile myoclonic epilepsy with lamotrigine.
Topics: Adolescent; Adult; Anticonvulsants; Female; Humans; Lamotrigine; Male; Myoclonic Epilepsy, Juvenile; | 2000 |
Juvenile myoclonic epilepsy--an experience from north western India.
Topics: Adolescent; Adult; Anticonvulsants; Child; Drug Administration Schedule; Female; Humans; India; Male | 2001 |
Evolution of juvenile myoclonic epilepsy treated from the outset with sodium valproate.
Topics: Adolescent; Adult; Age of Onset; Anticonvulsants; Child; Dose-Response Relationship, Drug; Electroen | 2001 |
Myoclonic status epilepticus: video presentation.
Topics: Adult; Combined Modality Therapy; Female; Humans; Myoclonic Epilepsy, Juvenile; Psychotherapy; Statu | 2002 |
Low dose sodium valproate in the treatment of juvenile myoclonic epilepsy.
Topics: Adolescent; Adult; Delayed-Action Preparations; Female; Humans; Male; Myoclonic Epilepsy, Juvenile; | 2002 |